1. Home
  2. IMAB vs ABAT Comparison

IMAB vs ABAT Comparison

Compare IMAB & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • ABAT
  • Stock Information
  • Founded
  • IMAB 2014
  • ABAT 2011
  • Country
  • IMAB United States
  • ABAT United States
  • Employees
  • IMAB N/A
  • ABAT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • ABAT Metal Mining
  • Sector
  • IMAB Health Care
  • ABAT Basic Materials
  • Exchange
  • IMAB Nasdaq
  • ABAT Nasdaq
  • Market Cap
  • IMAB 83.8M
  • ABAT 71.7M
  • IPO Year
  • IMAB 2020
  • ABAT N/A
  • Fundamental
  • Price
  • IMAB $0.94
  • ABAT $1.04
  • Analyst Decision
  • IMAB Strong Buy
  • ABAT
  • Analyst Count
  • IMAB 3
  • ABAT 0
  • Target Price
  • IMAB $8.00
  • ABAT N/A
  • AVG Volume (30 Days)
  • IMAB 288.7K
  • ABAT 586.7K
  • Earning Date
  • IMAB 08-28-2024
  • ABAT 11-15-2024
  • Dividend Yield
  • IMAB N/A
  • ABAT N/A
  • EPS Growth
  • IMAB N/A
  • ABAT N/A
  • EPS
  • IMAB N/A
  • ABAT N/A
  • Revenue
  • IMAB $3,313,984.00
  • ABAT $545,460.00
  • Revenue This Year
  • IMAB N/A
  • ABAT $31,748.62
  • Revenue Next Year
  • IMAB N/A
  • ABAT N/A
  • P/E Ratio
  • IMAB N/A
  • ABAT N/A
  • Revenue Growth
  • IMAB N/A
  • ABAT N/A
  • 52 Week Low
  • IMAB $0.90
  • ABAT $0.73
  • 52 Week High
  • IMAB $2.54
  • ABAT $6.45
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 38.29
  • ABAT 61.18
  • Support Level
  • IMAB $0.91
  • ABAT $0.83
  • Resistance Level
  • IMAB $1.11
  • ABAT $1.08
  • Average True Range (ATR)
  • IMAB 0.07
  • ABAT 0.09
  • MACD
  • IMAB -0.00
  • ABAT 0.01
  • Stochastic Oscillator
  • IMAB 13.01
  • ABAT 57.32

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About ABAT American Battery Technology Company

American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.

Share on Social Networks: